Endothelin receptor antagonists vs placebo
Change from baseline in PVR (dyn/s/cm5) mean duration of study 15.7 weeks · pulmonary arterial hypertension
1 finding from 1 review
- Endothelin receptor antagonists for pulmonary arterial hypertension 2021 · Cochrane Headline outcomes onlyno estimate extracted7 studies · 586 participantsModerate